Colorectal surgery obesity-related morbidity during COVID-19.
Antibodies, Monoclonal, Humanized
/ adverse effects
Betacoronavirus
COVID-19
Cecal Diseases
/ diagnosis
Coronavirus Infections
/ complications
Cytokine Release Syndrome
/ etiology
Female
Humans
Intestinal Perforation
/ diagnosis
Middle Aged
Obesity, Morbid
/ complications
Pandemics
Pneumonia, Viral
/ complications
SARS-CoV-2
COVID-19 Drug Treatment
Bowel perforation
COVID-19
Colonic perforation
Corticosteroids
IL-6
SARS-CoV-2 coronavirus
Tocilizumab
Journal
Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery
ISSN: 1878-7533
Titre abrégé: Surg Obes Relat Dis
Pays: United States
ID NLM: 101233161
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
28
05
2020
accepted:
05
06
2020
pubmed:
30
7
2020
medline:
10
9
2020
entrez:
30
7
2020
Statut:
ppublish
Résumé
Tocilizumab, a monoclonal antiinterluekin-6 receptor antibody, has been empirically used in the treatment of cytokine release syndrome associated with severe coronavirus disease 2019 infections. The efficacy and safety of these medications for these patients is unknown. The purpose of this report was to present a case of acute large bowel perforation in a morbidly obese patient with coronavirus disease 2019 pneumonia who received empiric Tocilizumab. This case report analyzes the risks of acute large bowel perforation after using this medication empirically and discusses the appropriate management of this adverse event.
Identifiants
pubmed: 32723601
pii: S1550-7289(20)30331-2
doi: 10.1016/j.soard.2020.06.011
pmc: PMC7346794
pii:
doi:
Substances chimiques
Antibodies, Monoclonal, Humanized
0
tocilizumab
I031V2H011
Types de publication
Case Reports
Journal Article
Video-Audio Media
Langues
eng
Sous-ensembles de citation
IM
Pagination
1372-1375Informations de copyright
Copyright © 2020 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.
Références
Int J Antimicrob Agents. 2020 May;55(5):105954
pubmed: 32234467
J Immunother Cancer. 2020 May;8(1):
pubmed: 32385146
Drug Discov Ther. 2020;14(2):73-76
pubmed: 32378648
JAMA. 2020 Jun 23;323(24):2493-2502
pubmed: 32392282
Int J Stroke. 2020 Jun;15(4):361-364
pubmed: 32310017
Gastroenterology. 2020 May;158(6):1518-1519
pubmed: 32142785
Thromb Res. 2020 Jul;191:145-147
pubmed: 32291094
Arch Surg. 1996 Jan;131(1):37-43
pubmed: 8546575
Int J Soc Psychiatry. 2020 Jun;66(4):317-320
pubmed: 32233719
Med Mal Infect. 2020 Aug;50(5):397-400
pubmed: 32387320
Circ Cardiovasc Qual Outcomes. 2020 Apr;13(4):e006631
pubmed: 32182131
Sci Total Environ. 2020 Aug 1;728:138882
pubmed: 32335410
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(4):260-261
pubmed: 32352517
J Thromb Haemost. 2020 Jun;18(6):1324-1329
pubmed: 32306492
Arthritis Rheumatol. 2016 Nov;68(11):2612-2617
pubmed: 27213279
Ann Rheum Dis. 2017 Mar;76(3):504-510
pubmed: 27405509
J Hosp Infect. 2020 Jun;105(2):142-145
pubmed: 32339615
Colorectal Dis. 2020 Jun;22(6):635-640
pubmed: 32359223
J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973
pubmed: 32311448
Am J Surg. 2020 Jun;219(6):903-906
pubmed: 32334800